{
  "resourceType": "ValueSet",
  "id": "immunosuppressive-permament-medications",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=116566001\">116566001</a></td><td>Steroid (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=416798007\">416798007</a></td><td>Substance with calcineurin inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=372669002\">372669002</a></td><td>Alkylating agent (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=430866006\">430866006</a></td><td>Substance with interleukin 1 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=784015001\">784015001</a></td><td>Substance with interleukin 6 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=771592004\">771592004</a></td><td>Substance with interleukin 23 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=870401008\">870401008</a></td><td>Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=768651008\">768651008</a></td><td>Antithymocyte immunoglobulin (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=372917005\">372917005</a></td><td>Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=48583005\">48583005</a></td><td>Immunoglobulin E (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=49327004\">49327004</a></td><td>Interferon (substance)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=74964007\">74964007</a></td><td>Other (qualifier value)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=260413007\">260413007</a></td><td>None (qualifier value)</td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=261665006\">261665006</a></td><td>Unknown (qualifier value)</td></tr></table></li><li>Include these codes as defined in <code>http://fhir.de/CodeSystem/bfarm/atc</code> version <code>2020</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01EG\">L01EG</a></td><td>Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01B\">L01B</a></td><td>ANTIMETABOLITEN</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L04AB\">L04AB</a></td><td>Tumornekrosefaktor alpha (TNF-alpha)-Inhibitoren</td></tr><tr><td><a href=\"?ngen-14?.html#CodeSystemATC2021-L01EJ\">L01EJ</a></td><td>Janus-assoziierte Kinase (JAK)-Inhibitoren</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-napkon-pediatrics-module.html\"><code>https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000001\">000001</a></td><td>Sphingosine analogue (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000002\">000002</a></td><td>Substance with interleukin 2 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000003\">000003</a></td><td>Substance with interleukin 17 receptor antagonist mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000004\">000004</a></td><td>Anti-CD20 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000005\">000005</a></td><td>Anti-CD52 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000006\">000006</a></td><td>Anti-CD3 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000007\">000007</a></td><td>Anti-CD3/CD19 antibody (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000008\">000008</a></td><td>Substance with Integrin inhibitor mechanism of action (substance)</td></tr><tr><td><a href=\"CodeSystem-napkon-pediatrics-module.html#napkon-pediatrics-module-000009\">000009</a></td><td>Substance with B cell activating factor inhibitor mechanism of action (substance)</td></tr></table></li></ul></div>"
  },
  "url": "https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/immunosuppressive-permament-medications",
  "version": "0.1.0",
  "name": "ImmunosuppressivePermanentMedications",
  "title": "Immunosuppressive Permanent Medications",
  "status": "draft",
  "date": "2021-10-05",
  "publisher": "BIH @ Charité",
  "contact": [
    {
      "name": "BIH @ Charité",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.netzwerk-universitaetsmedizin.de"
        }
      ]
    }
  ],
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "116566001",
            "display": "Steroid (substance)"
          },
          {
            "code": "416798007",
            "display": "Substance with calcineurin inhibitor mechanism of action (substance)"
          },
          {
            "code": "372669002",
            "display": "Alkylating agent (substance)"
          },
          {
            "code": "430866006",
            "display": "Substance with interleukin 1 receptor antagonist mechanism of action (substance)"
          },
          {
            "code": "784015001",
            "display": "Substance with interleukin 6 receptor antagonist mechanism of action (substance)"
          },
          {
            "code": "771592004",
            "display": "Substance with interleukin 23 receptor antagonist mechanism of action (substance)"
          },
          {
            "code": "870401008",
            "display": "Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance)"
          },
          {
            "code": "768651008",
            "display": "Antithymocyte immunoglobulin (substance)"
          },
          {
            "code": "372917005",
            "display": "Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)"
          },
          {
            "code": "48583005",
            "display": "Immunoglobulin E (substance)"
          },
          {
            "code": "49327004",
            "display": "Interferon (substance)"
          },
          {
            "code": "74964007",
            "display": "Other (qualifier value)"
          },
          {
            "code": "260413007",
            "display": "None (qualifier value)"
          },
          {
            "code": "261665006",
            "display": "Unknown (qualifier value)"
          }
        ]
      },
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "version": "2020",
        "concept": [
          {
            "code": "L01EG",
            "display": "Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren"
          },
          {
            "code": "L01B",
            "display": "ANTIMETABOLITEN"
          },
          {
            "code": "L04AB",
            "display": "Tumornekrosefaktor alpha (TNF-alpha)-Inhibitoren"
          },
          {
            "code": "L01EJ",
            "display": "Janus-assoziierte Kinase (JAK)-Inhibitoren"
          }
        ]
      },
      {
        "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module",
        "concept": [
          {
            "code": "000001",
            "display": "Sphingosine analogue (substance)"
          },
          {
            "code": "000002",
            "display": "Substance with interleukin 2 receptor antagonist mechanism of action (substance)"
          },
          {
            "code": "000003",
            "display": "Substance with interleukin 17 receptor antagonist mechanism of action (substance)"
          },
          {
            "code": "000004",
            "display": "Anti-CD20 antibody (substance)"
          },
          {
            "code": "000005",
            "display": "Anti-CD52 antibody (substance)"
          },
          {
            "code": "000006",
            "display": "Anti-CD3 antibody (substance)"
          },
          {
            "code": "000007",
            "display": "Anti-CD3/CD19 antibody (substance)"
          },
          {
            "code": "000008",
            "display": "Substance with Integrin inhibitor mechanism of action (substance)"
          },
          {
            "code": "000009",
            "display": "Substance with B cell activating factor inhibitor mechanism of action (substance)"
          }
        ]
      }
    ]
  }
}